{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T17:03:54Z","timestamp":1732035834598},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T00:00:00Z","timestamp":1447286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0142310","type":"journal-article","created":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T20:04:24Z","timestamp":1447358664000},"page":"e0142310","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia"],"prefix":"10.1371","volume":"10","author":[{"given":"Mohammad","family":"Hojjat-Farsangi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood","family":"Jeddi-Tehrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Hossein","family":"Daneshmanesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariba","family":"Mozaffari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Moshfegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotta","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohsen","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramazan Ali","family":"Sharifian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hodjattallah","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"\u00d6sterborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e5kan","family":"Mellstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazel","family":"Shokri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,11,12]]},"reference":[{"key":"ref1","first-page":"605","article-title":"Chronic lymphocytic leukaemia","volume":"29","author":"J Boelens","year":"2009","journal-title":"Anticancer Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.194.11.1625","article-title":"Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells","volume":"194","author":"U Klein","year":"2001","journal-title":"J Exp Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","article-title":"Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia","volume":"194","author":"A Rosenwald","year":"2001","journal-title":"J Exp Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"26181","DOI":"10.1016\/S0021-9258(18)35733-8","article-title":"A novel family of cell surface receptors with tyrosine kinase-like domain","volume":"267","author":"P Masiakowski","year":"1992","journal-title":"J Biol Chem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2141.2007.06875.x","article-title":"Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes","volume":"139","author":"C Plass","year":"2007","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.semcancer.2014.07.005","article-title":"The receptor tyrosine kinase ROR1\u2014an oncofetal antigen for targeted cancer therapy","volume":"29","author":"M Hojjat-Farsangi","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/RRS-120018757","article-title":"Expression and function of the Ror-family receptor tyrosine kinases during development: lessons from genetic analyses of nematodes, mice, and humans","volume":"23","author":"A Yoda","year":"2003","journal-title":"J Recept Signal Transduct Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1158\/1078-0432.CCR-07-1823","article-title":"Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia","volume":"14","author":"S Baskar","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/ijc.23587","article-title":"Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy","volume":"123","author":"AH Daneshmanesh","year":"2008","journal-title":"Int J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.0712148105","article-title":"Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a","volume":"105","author":"T Fukuda","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","article-title":"Preclinical Development Of ROR1 Peptide Based Vaccine With Activity Against Chronic Lymphocytic Leukemia In ROR1 Transgenic Mice","volume":"122","author":"J Yu","year":"2013","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e61167","DOI":"10.1371\/journal.pone.0061167","article-title":"Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells","volume":"8","author":"M Hojjat-Farsangi","year":"2013","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/leu.2011.362","article-title":"Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells","volume":"26","author":"AH Daneshmanesh","year":"2012","journal-title":"Leukemia"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2141.2001.03117.x","article-title":"Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern","volume":"115","author":"MR Rezvany","year":"2001","journal-title":"Br J Haematol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00262-011-1149-5","article-title":"Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria","volume":"61","author":"M Palma","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/eji.1830220404","article-title":"Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes","volume":"22","author":"J Morrison","year":"1992","journal-title":"Eur J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4049\/jimmunol.150.5.1763","article-title":"Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells","volume":"150","author":"HJ Zweerink","year":"1993","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/annonc\/mdn017","article-title":"Idiotype vaccination in patients with myeloma reduced circulating myeloma cells (CMC)","volume":"19","author":"AO Abdalla","year":"2008","journal-title":"Ann Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e78339","DOI":"10.1371\/journal.pone.0078339","article-title":"The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells","volume":"8","author":"M Hojjat-Farsangi","year":"2013","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000082102","article-title":"The biology of CD20 and its potential as a target for mAb therapy","volume":"8","author":"MS Cragg","year":"2005","journal-title":"Curr Dir Autoimmun"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0925-4773(01)00383-5","article-title":"Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development","volume":"105","author":"T Matsuda","year":"2001","journal-title":"Mech Dev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s004270100140","article-title":"Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development","volume":"211","author":"R Al-Shawi","year":"2001","journal-title":"Dev Genes Evol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood-2009-09-242438","article-title":"Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway","volume":"115","author":"R Lapalombella","year":"2010","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s13277-012-0628-4","article-title":"Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia","volume":"34","author":"F Jadidi-Niaragh","year":"2013","journal-title":"Tumour Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1007\/s12032-012-0262-4","article-title":"Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia","volume":"29","author":"F Jadidi-Niaragh","year":"2012","journal-title":"Med Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/07357907.2012.756110","article-title":"Increased frequency of CD8+ and CD4+ regulatory T cells in chronic lymphocytic leukemia: association with disease progression","volume":"31","author":"F Jadidi-Niaragh","year":"2013","journal-title":"Cancer Invest"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/1042819021000029993","article-title":"Abnormal T-cell function in B-cell chronic lymphocytic leukaemia","volume":"44","author":"S Scrivener","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1038\/bcj.2013.45","article-title":"Role of the B-cell receptor and the microenvironment in chronic lymphocytic leukemia","volume":"3","author":"P Oppezzo","year":"2013","journal-title":"Blood Cancer J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJM200103013440907","article-title":"Tolerance and autoimmunity","volume":"344","author":"T Kamradt","year":"2001","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.3109\/10428194.2012.681657","article-title":"Complement dependent cytotoxicity in chronic lymphocytic leukemia: ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement","volume":"53","author":"NA Baig","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1016\/j.molimm.2007.06.151","article-title":"Mechanisms of killing by anti-CD20 monoclonal antibodies","volume":"44","author":"MJ Glennie","year":"2007","journal-title":"Mol Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2010-05-283309","article-title":"The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor","volume":"116","author":"M Hudecek","year":"2010","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1056\/NEJMra072739","article-title":"Cancer immunology","volume":"358","author":"OJ Finn","year":"2008","journal-title":"N Engl J Med"},{"key":"ref34","first-page":"108","article-title":"Challenges and prospects of immunotherapy as cancer treatment","volume":"1776","author":"M Rescigno","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"ref35","first-page":"4","article-title":"Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients","volume":"10","author":"N Lendvai","year":"2010","journal-title":"Cancer Immun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/j.1349-7006.2008.00860.x","article-title":"Humoral immune responses against tumor-associated antigen OVA66 originally defined by serological analysis of recombinant cDNA expression libraries and its potentiality in cellular immunity","volume":"99","author":"S Jin","year":"2008","journal-title":"Cancer Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(06)95001-5","article-title":"NY-ESO-1: review of an immunogenic tumor antigen","volume":"95","author":"S Gnjatic","year":"2006","journal-title":"Adv Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1182\/blood-2004-09-3707","article-title":"NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses","volume":"105","author":"F van Rhee","year":"2005","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000055289","article-title":"Vaccination for malignant melanoma: recent developments","volume":"60","author":"D Jager","year":"2001","journal-title":"Oncology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0163-7258(03)00056-1","article-title":"Immune responses in cancer","volume":"99","author":"JK Adam","year":"2003","journal-title":"Pharmacol Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/172460080001500413","article-title":"Human MUC1 mucin: a multifaceted glycoprotein","volume":"15","author":"S von Mensdorff-Pouilly","year":"2000","journal-title":"Int J Biol Markers"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1073\/pnas.1308374111","article-title":"ROR1 can interact with TCL1 and enhance leukemogenesis in Emu-TCL1 transgenic mice","volume":"111","author":"GF Widhopf 2nd","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/bjh.13228","article-title":"The PI3K\/AKT\/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodies","volume":"169","author":"AH Daneshmanesh","year":"2015","journal-title":"Br J Haematol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0142310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T20:59:43Z","timestamp":1692133183000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0142310"}},"subtitle":[],"editor":[{"given":"Spencer B.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,12]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0142310","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,12]]}}}